EMAIL THIS PAGE TO A FRIEND

Neurology

Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients: dose-response study and correlations with plasma levels.


PMID 8857741

Abstract

To determine if ventricular cerebrospinal fluid (vCSF) alpha-tocopherol levels in Parkinson's disease (PD) patients can be increased by oral alpha-tocopherol supplementation and whether vCSF levels are linearly related to plasma alpha-tocopherol levels. In spite of its putative neuroprotective properties, alpha-tocopherol has failed to alter PD clinical progression. However, the ability of supplemental alpha-tocopherol to affect brain or vCSF levels has never been assessed in humans nor has a dose response curve for alpha-tocopherol in vCSF been established. Five PD patients with Ommaya catheters received oral dl-alpha-tocopherol over 5 months. Each patient ingested alpha-tocopherol daily with monthly dosage increases (400, 800, 1,600, 3,200, 4,000 IU/day). Plasma and vCSF samples were obtained at baseline and at the end of each month. Alpha-tocopherol levels were determined in triplicate by high-pressure liquid chromatography with fluorometric and electrochemical detection. At baseline, endogenous alpha-tocopherol was detected in plasma and vCSF, with a greater than one-hundred-fold difference between the fluid compartments (mean plasma level 18.76 microM/l (SD +/- 4.69) versus mean CSF level 0.114 microM/l (SD +/- 0.084). A clear dose-response curve occurred in plasma, with statistically significant increases over baseline developing even with 400 IU/d. With higher doses, a significant increase continued without evidence of saturation. However, there was no significant increase in vCSF alpha-tocopherol levels at any dose, including the supraclinical (4,000 IU/d). There was no correlation between plasma and vCSF alpha-tocopherol levels. Oral alpha-tocopherol supplementation, even at supraclinical doses, fails to increase vCSF alpha-tocopherol levels. This lack of change may be due to limited passage across the blood-brain barrier or very rapid alpha-tocopherol metabolism. All prior negative studies on efficacy of alpha-tocopherol in PD may need reevaluation in light of these pharmacologic data.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

266523
Aluminum, ReagentPlus®, beads, 5-15 mm, 99.9% trace metals basis
Al
433705
Aluminum, evaporation slug, diam. × L 6.3 mm × 6.3 mm, 99.999% trace metals basis
Al
518573
Aluminum, granular, <1 mm, 99.7% trace metals basis
Al
266957
Aluminum, foil, thickness 1.0 mm, 99.999% trace metals basis
Al
266574
Aluminum, foil, thickness 0.45-0.55 mm, 99.999% trace metals basis
Al
326852
Aluminum, foil, thickness 0.25 mm, 99.999% trace metals basis
Al
326860
Aluminum, foil, thickness 0.13 mm, ≥99.99% trace metals basis
Al
11008
Aluminum, grit, ≥97.0% (complexometric)
Al
653608
Aluminum, powder, <5 μm particle size, 99.5% trace metals basis
Al
326941
Aluminum, pellets, 3-8 mesh, ≥99.999% trace metals basis
Al
338788
Aluminum, pellets, 3-12 mm, 99.99% trace metals basis
Al
202584
Aluminum, powder, <75 μm, ≥99.95% trace metals basis
Al
266515
Aluminum, ≤30 μm, spherical powder, ≥99%
Al
11009
Aluminum, powder, ≥91% (complexometric)
Al
202576
Aluminum, rod, diam. × L 3.0 mm × 100 mm, 99.999% trace metals basis
Al
310360
Aluminum, ACS reagent, 99%, wire, wire diam. ~1.5 mm
Al
266558
Aluminum, wire, diam. 1.0 mm, 99.999% trace metals basis
Al
326887
Aluminum, wire, diam. 0.58 mm, ≥99.99% trace metals basis
Al
11010
Aluminum, powder (fine), ≥93% (complexometric)
Al
IRMM523A
Aluminum, IRMM® certified Reference Material, 0.1 mm foil
Al
IRMM523B
Aluminum, IRMM® certified Reference Material, 1.0 mm foil
Al
IRMM523C
Aluminum, IRMM® certified Reference Material, 1.0 mm wire
Al
733369
Aluminum, foil, thickness 8 μm, 99% trace metals basis
Al
749036
Aluminum, sputtering target, diam. × thickness 3.00 in. × 0.125 in., 99.9995% trace metals basis
Al
773964
Aluminum, ingot, L × W 10 mm × 7 mm, 99.99995% trace metals basis
Al
265063
Beryllium, chunks, 99.9%
Be
378135
Beryllium, powder, −325 mesh, ≥99%
Be
452386
Bismuth, beads, 1-5 mm, 99.999% trace metals basis
Bi
95372
Bismuth, granular, ≥99.99% trace metals basis
Bi
556130
Bismuth, pieces, 1-12 mm, 99.999% trace metals basis
Bi